Next Article in Journal
Chemical Constituents of Three Allium Species from Romania
Previous Article in Journal
Brønsted Acidic Ionic Liquid Accelerated Halogenation of Organic Compounds with N-Halosuccinimides (NXS)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 18
Issue 1
10.3390/molecules18010097
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series

by
Anita Cohen
1,2,
Maxime D. Crozet
1,
Pascal Rathelot
1,
Nadine Azas
2,* and
Patrice Vanelle
2,*
1
Laboratoire de Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Institut de Chimie Radicalaire ICR UMR 7273, Aix-Marseille Univ, CNRS, 27 Boulevard Jean Moulin - CS30064 - 13385 Marseille cedex 05, France
2
Infections Parasitaires, Transmission, Pharmacologie et Thérapeutique IP-TPT UMR MD3, Faculté de Pharmacie, Aix-Marseille Univ, 27 Boulevard Jean Moulin - CS30064 - 13385 Marseille cedex 05, France
*
Authors to whom correspondence should be addressed.
Molecules 2013, 18(1), 97-113; https://doi.org/10.3390/molecules18010097
Submission received: 6 November 2012 / Revised: 14 November 2012 / Accepted: 12 December 2012 / Published: 21 December 2012
(This article belongs to the Section Medicinal Chemistry)
Browse Figures
Versions Notes

Abstract

:
The synthesis in water of new sulfone derivatives under microwave irradiation is described. This eco-friendly process leads to the expected products in good yields by reaction of various substituted sulfinates (commercially available or obtained by reduction of the corresponding sulfonyl chlorides) with 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole. In order to evaluate the antiproliferative effect of these compounds, several sulfone derivatives are also dichlorinated on the Cα next to the sulfonyl group. An evaluation on different cancer cell lines reveals promising selective in vitro antiproliferative activity toward HepG2 human cell lines by dihydrogenated sulfones, suggesting further research should be to explore their anticancer potential in the treatment of liver cancer.

1. Introduction

Recent years have seen major advances in research and development concerning new small molecules whose antiproliferative activity appears promising for the treatment of cancer [1,2]. Among chemical compounds already developed as potential anticancer agents, some sulfones [3,4] such as celecoxib [5], and heterocyclic molecules such as thiazole derivatives [6,7], have recently been reported to display promising antiproliferative activity.
Thiazoles are one of the most prevalent heterocyclic nuclei, among compounds displaying biological activities [8], such as β-lactams [9,10,11], urate-lowering drugs (febuxostat) [12], or antiparasitic agents [13,14,15]. Furthermore, sulfonylmethyl groups are well-known to be useful in synthetic methodologies and they can be used further for the preparation of various functionalized products. For example, the expected acidity of the C-Hα next to sulfonyl groups offers the opportunity to carry out various reactions at this position [16,17,18].
In continuation of our research program centered on the design and synthesis of novel molecules, we focused our work on the synthesis and the evaluation of some new heterocyclic compounds displaying diverse biological activities [19,20,21,22,23,24]. In this context, we decided to explore the antiproliferative potential of new sulfonyl derivatives in the 5-nitro-1,3-thiazole series. We report herein the synthesis of such molecules from the reaction in water of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) with various sulfinate anions under microwave irradiation. This is in continuation of our research program directed towards the study of electron transfer reactions in heterocyclic series [25,26] and microwave-assisted [27,28] eco-friendly processes [29,30]. The antiproliferative activity both of sulfones and of some α-dichlorinated sulfonyl derivatives was comparatively evaluated on the CHO and HepG2 cell lines, and results confirmed the promising antiproliferative effect of dihydrogenated sulfones towards the HepG2 cell line.

2. Results and Discussion

2.1. Chemistry

The required starting material, 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1), was prepared in 62% overall yield by sequential condensation between 1,3-dichloroacetone with thioacetamide [31], cyclization using ZnCl2 in refluxing methanol, and nitration of 2-methyl-4-chloromethyl-1,3-thiazole hydrochloride [32] (Scheme 1).
Molecules 18 00097 g002 550
Scheme 1. Preparation of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) [32].
Scheme 1. Preparation of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) [32].
Molecules 18 00097 g002
The synthesis of 2-methyl-5-nitro-4-phenylsulfonylmethyl-1,3-thiazole (2a) by reaction of 1 with sodium phenylsulfinate in anhydrous methanol, under SRN1 conditions [33,34] (inert atmosphere (Ar) and 60 W lamp irradiation), at room temperature (rt) for 24 h [32] has already been described. Based on a number of reports suggesting that chemical reactions using water as a solvent in conjunction with microwave heating [35,36,37] were more eco-friendly, we adapted this alternative method to the synthesis of 2a. Water is an attractive alternative to traditional organic solvents due to its practical advantages: it is inexpensive, non-flammable, non-toxic, and environmentally sustainable as it removes the problem of pollution by organic solvents. Water has also proven to be an excellent solvent for microwave-promoted synthesis [38,39,40]. Furthermore, as well as being energy efficient, microwaves can also enhance reaction rates, and in many cases, improve yields [41,42,43,44].
Based on previous results for reduction reaction using microwave promotion, an initial irradiation of 500 W at a temperature of 100 °C was applied [45]. We subsequently tried reducing the irradiation power, finally establishing that the optimal experimental conditions to carry out the reactions under microwave irradiation were 200 W and a temperature held at 100 °C until the completion of the reaction (Scheme 2). In order to evaluate the efficiency of these latter experimental conditions versus classical heating as previously described, we compared the synthesis of 2-methyl-5-nitro-4-phenylsulfonylmethyl-1,3-thiazole (2a) by the two methods (classical heating in methanol [32] versus microwave irradiation in water). As expected, it proved more convenient to carry out the reaction in water and using microwave technology (Table 1 entry 1). Indeed, it took only 30 min to complete the reaction with an excellent yield (96%) under these conditions, while the classical heating conditions required a reaction time of 24 h to synthesize 2a in a lower yield (84%). The reaction rate was thus, accelerated up to 48 times, and led to higher yields.
Molecules 18 00097 g003 550
Scheme 2. Preparation of sulfones 2a, 2b, 2c by reaction of the corresponding commercialized sulfinate salts with 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1).
Scheme 2. Preparation of sulfones 2a, 2b, 2c by reaction of the corresponding commercialized sulfinate salts with 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1).
Molecules 18 00097 g003
Following these excellent first results, we extended the study to p-tosyl and p-chlorophenyl sulfinate anions, with a view to exploring the chemical and biological influence of the electron-donating or -withdrawing character of the substrates. These reagents led to 2-methyl-5-nitro-4-(tosylmethyl)-1,3-thiazole (2b) and 4-[(4-chlorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2c), respectively (Table 1 entries 2 and 3). Similar good results were observed, which confirmed that the microwave-assisted method led to a more rapid and efficient synthesis of original sulfones.
Table
Table 1. Classical heating method versus microwave-assisted synthesis of sulfones 2a to 2c.
Table 1. Classical heating method versus microwave-assisted synthesis of sulfones 2a to 2c.
EntryAr-ProductProduct numberClassical heating conditions aMicrowave irradiation conditions b
Time (h)Yield (%)Time (h)Yield (%)
1C6H5- Molecules 18 00097 i0012a2484 [32]0.596
2p-CH3-C6H4- Molecules 18 00097 i0022b24570.586
3p-Cl-C6H4- Molecules 18 00097 i0032c24690.576
a This method was performed using 1 equivalent (equiv.) of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) and 2 equiv. of sodium arylsulfinate derivative in anhydrous methanol (10 mL), under inert atmosphere (Ar) and 60 W lamp irradiation, at rt. b This method was performed using 1 equiv. of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) and 2 equiv. of sodium arylsulfinate derivative in water (20 mL). An initial microwave irradiation of 200 W was used, the temperature being ramped up from r.t. to 100 °C and then held at 100 °C until the end of the reaction.
Next, to further diversify the chemical substituents on the sulfonyl group and to evaluate their influence on the antiproliferative activity of the corresponding products, these microwave-assisted operating conditions were used to synthesize new sulfonyl derivatives of 1 by reactions with various substituted sulfinate substrates. As such sulfinate salts are not commercially available, we performed the sodium-mediated reduction of sulfonyl chloride derivatives into the corresponding sulfinate anions, in aqueous conditions [46,47] and under microwave irradiation. Then, we investigated the above method using a mixture of sodium sulfite, sodium bicarbonate and sulfonyl chloride derivatives [48] and adapted it to the microwave methodology. Thus, the reduction of sulfonyl chloride derivatives was conducted with 3.4 equiv. of Na2SO3, 3.4 equiv. of NaHCO3, and 1 equiv. of the sulfonyl chloride derivative, in water at 100 °C, under microwave irradiation for 0.42 h. The compound 1 was directly added to the crude mixture, which was stirred for 0.5 h under the above conditions (MW 200 W, 100 °C) to give the corresponding sulfones 2d to 2l (Scheme 3) in moderate to good yields in a one-pot protocol (Table 2).
Molecules 18 00097 g004 550
Scheme 3. Preparation of sulfones 2d to 2l.
Scheme 3. Preparation of sulfones 2d to 2l.
Molecules 18 00097 g004
Table
Table 2. Microwave mediated preparation of several sulfones derivatives of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1).
Table 2. Microwave mediated preparation of several sulfones derivatives of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1).
R-ProductProduct numberYield (%)
p-Br-C6H4- Molecules 18 00097 i0042d68
p-F-C6H4- Molecules 18 00097 i0052e82
m-F-C6H4- Molecules 18 00097 i0062f65
m-CF3-C6H4- Molecules 18 00097 i0072g71
p-CH3O-C6H4- Molecules 18 00097 i0082h60
p-C2H5-C6H4- Molecules 18 00097 i0092i31
CH3- Molecules 18 00097 i0102j52
2-bromothiophenyl- Molecules 18 00097 i0112k58
2-naphthyl- Molecules 18 00097 i0122l90
All the reactions were performed using 2 equiv. of sulfonyl chloride, 3.4 equiv. of sodium sulfite, 3.4 equiv. of sodium carbonate in water (30 mL). An initial microwave irradiation of 200 W was used, the temperature being ramped up from r.t. to 100 °C, where it was held for 0.42 h. 1 equiv. of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) was then added to the crude mixture, which was subsequently heated for 0.5 h.
To assess the importance of the methyl group next to sulfonyl for the biological activity, we then evaluated a group of α-dichlorinated sulfonyl derivatives 3a to 3e. These compounds were prepared by reaction of sulfonyl derivatives with hypochlorite-based bleach (2.6% active chlorine) under lower microwave irradiation conditions (75 W, 40 °C) [49] (Scheme 4). Dichlorinated analogs were obtained in good yields (Table 3).
Molecules 18 00097 g005 550
Scheme 4. Preparation of dichlorinated sulfones 3a to 3e.
Scheme 4. Preparation of dichlorinated sulfones 3a to 3e.
Molecules 18 00097 g005
Table
Table 3. Microwave-mediated preparation of dichlorinated sulfone derivatives.
Table 3. Microwave-mediated preparation of dichlorinated sulfone derivatives.
R-ProductProduct numberYield (%)
C6H5- Molecules 18 00097 i0133a81
p-CH3-C6H4- Molecules 18 00097 i0143b61
-Cl-C6H4- Molecules 18 00097 i0153c68
p-Br-C6H4- Molecules 18 00097 i0163d79
p-F-C6H4- Molecules 18 00097 i0173e88
All the reactions were performed using 1 equiv. of sulfonyl derivative (2a to 2f) in 10 mL of sodium hypochlorite. A microwave irradiation of 75 W was used, the temperature being ramped up from r.t. to 40 °C, where the mixture was then held for 1 to 3.75 h.
The structure of compound 3c was unambiguously confirmed by X-ray structure analysis (Figure 1) (CCDC 908240). The other structures were assigned by analogy and spectral comparison.
Molecules 18 00097 g001 550
Figure 1. X-Ray structure of compound 3c.
Figure 1. X-Ray structure of compound 3c.
Molecules 18 00097 g001

2.2. In Vitro Biological Evaluation

The antiproliferative activity of the synthesized compounds was evaluated against two different cancer cell lines, CHO and HepG2, employing the MTT method [50] and doxorubicin as a reference drug. The cytotoxic activity in vitro was expressed as CC50 (µM), the concentration of compound that inhibits proliferation of cells by 50% as compared to untreated cells. The results of substance screening are summarized in Table 4.
All dihydrogenated sulfonyl derivatives displayed substantial antiproliferative activity towards HepG2 cells (7.7 µM ≤ HepG2 CC50 ≤ 25.6 µM) compared with doxorubicin used as reference drug (HepG2 CC50 = 0.2 µM), except compounds 2i and 2j for which no activity was observed on either of the cell lines. These data show that neither an elongation of the carbon chain at the p-position of the phenyl substituent nor an alkyl substituent on the sulfonyl group appears to favour the antiproliferative effects.
Table
Table 4. Antiproliferative activity of compounds 2a to 3e.
Table 4. Antiproliferative activity of compounds 2a to 3e.
Product NumberCancer cell toxicity a (µM)
CHO CC50HepG2 CC50
2a322.9 (± 4.66)24.6 (± 0.78)
2b237.3 (± 5.55)7.7 (± 1.42)
2c>62.5 c13.4 (± 1.47)
2d>500 c11.7 (± 2.09)
2e229.3 (± 4.02)19.3 (± 1.21)
2f321.1 (± 3.23)23.6 (± 0.58)
2g138.6 (± 2.64)25.6 (± 2.13)
2h136.8 (± 4.26)20.6 (± 0.74)
2i>500 c238.9 (± 2.27)
2j>250 c>250 c
2k47.3 (± 2.28)13.8 (± 1.07)
2l106.2 (± 4.90)8.5 (± 1.52)
3a2.5 (± 0.23)1.2 (± 0.09)
3b1.2 (± 0.11)1.0 (± 0.24)
3c1.4 (± 0.06)1.1 (± 0.17)
3d1.3 (± 0.04)1.2 (± 0.22)
3e1.3 (± 0.04)1.2 (± 0.34)
Doxorubicin b0.60.2
a CC50 (µM) indicates the compound concentration that inhibits the proliferation of cells by 50% as compared to control untreated cells. The values are means ± SD of three independent experiments. b Doxorubicin was used as reference drug compound for cell toxicity. c No toxicity at the highest tested concentration.
Furthermore, this series was generally inactive on CHO cells, with CC50 values of between 47.3 and ≥500 µM, compared with doxorubicin (CHO CC50 = 0.6 µM). HepG2 is a commonly used human-derived hepatocarcinoma cell line expressing many of the hepatocyte-specific metabolic enzymes. The aim of this assay using HepG2 in addition to CHO cells was to evaluate the impact of metabolic activation of the tested compounds on cell viability [51]. Our results indicate that dihydrogenated sulfonyl derivatives, apart from 2i and 2j, need to be modified by a metabolic pathway to offer promising antiproliferative activity. Compounds 2b and 2d in particular displayed an antiproliferative effect 31 and 43 times higher respectively toward the HepG2 than toward the CHO cell line, which confirmed their high specificity for human liver tumor cells.
Dichlorinated sulfones 3a to 3e were much more cytotoxic toward both the cell lines (1.0 µM ≤ CC50 ≤ 2.5 µM) than their dihydrogenated analogs, compared with doxorubicin used as reference of cellular toxicity. This result highlights the lack of cellular specificity of dichlorinated derivatives, confirming that the methyl group next to sulfonyl plays a key role in the antiproliferative activity of this series on human liver tumor cells.

3. Experimental

3.1. General

Melting points were determined on a Büchi B-540 and are uncorrected. Elemental analyses were carried out on an Interscience Flash EA 1112 series (Thermo Finnigan, San Jose, CA, USA) elemental analyzer at the Spectropole, Faculté des Sciences et Techniques de Saint-Jérome. Both 1H- and 13C-NMR spectra were determined on a Bruker Avance 200 spectrometer (operating at 200 MHz for 1H and 50 MHz for 13C). 1H and 13C-NMR shifts (δ) were reported in parts per million (ppm) with respect to CDCl3 7.26 ppm for 1H and 77.0 ppm for 13C and DMSO-d6 2.50 for 1H and 39.7 ppm for 13C. Multiplicities were represented by s (singlet), d (doublet), t (triplet), q (quartet) and m (multiplet). Coupling constants (J) are in Hertz (Hz). The following adsorbent was used for column chromatography: silica gel 60 (Merck, Darmstadt, Germany, 230–400 mesh). Thin-layer chromatography was performed with Merck 60F-254 silica gel (0.25 mm layer thickness) in an appropriate solvent. All the reactions involving microwave instrumentation used the ETHOS Synth Lab station multimode reactor (Ethos Start, Milestone Inc., Rockford, IL, USA). The multimode microwave had a 25 twin magnetron (2 × 800 W, 2.45 GHz) with a maximum delivered power of 1,000 W in 10 W increments (pulsed irradiation). The multimode microwave featured a built-in magnetic stirrer (Teflon-coated stirring bar), direct temperature control of the reaction mixture with the aid of IR30 sensor on the reactor wall and software that enabled on line temperature control by regulation of microwave power output.

3.2. General Procedure for the Reaction of Compound 1 and Sodium Arylsulfinates to Synthesize Products 2a to 2c and Using Classical Heating Conditions

The corresponding sodium arylsulfinate (2 equiv.) was added to a solution of 1 (1 g, 5.2 mmol) in anhydrous methanol (10 mL). The reaction mixture was stirred at r.t., for 24 h, under an inert atmosphere (Ar) and 60 W lamp irradiation. After removal of the reaction mixture under reduced pressure, purification by chromatography on silica gel, elution with ethyl acetate and recrystallization from isopropanol (i-PrOH), the corresponding 4-arylsulfonylmethyl-2-methyl-5-nitro-1,3-thiazole was obtained.

3.3. General Procedure for the Reaction of Compound 1 and Sodium Arylsulfinates to Synthesize Products 2a to 2c and Using Microwave Irradiation

The corresponding sodium arylsulfinate (2 equiv.) was added to a solution of 1 (1 g, 5.2 mmol) in water (20 mL). The reaction mixture was irradiated in a microwave oven (200 W, 100 °C, 0.5 h). A precipitate appeared and was filtered after cooling, washed with water (3 × 20 mL) and dried in a vacuum drying oven. Recrystallization from i-PrOH gave the corresponding sulfonyl derivative.
2-Methyl-5-nitro-4-(tosylmethyl)-1,3-thiazole (2b): Yellow solid; m.p. 179 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.43 (s, 3H, CH3), 2.70 (s, 3H, CH3), 5.02 (s, 2H, CH2), 7.31 (d, J = 7.9 Hz, 2H, 2 × CH), 7.68 (d, J = 7.9 Hz, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.4 (CH3), 21.7 (CH3), 56.7 (CH2), 128.3 (2 × CH), 129.9 (2 × CH), 135.8 (C), 143.3 (C), 145.4 (C), 169.3 (C), C-NO2 not visible under these conditions; Anal. Calcd for C12H12N2O4S2: C, 46.14; H, 3.87; N, 8.97. Found: C, 46.41; H, 3.89; N, 9.07.
4-[(4-Chlorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2c): Yellow solid; m.p. 180 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.70 (s, 3H, CH3), 5.04 (s, 2H, CH2), 7.51 (d, J = 8.8 Hz, 2H, 2 × CH), 7.76 (d, J = 8.8 Hz, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.4 (CH3), 56.7 (CH2), 129.6 (2 × CH), 129.9 (2 × CH), 137.3 (C), 141.2 (C), 142.8 (C), 169.5 (C), C-NO2 not visible under these conditions; Anal. Calcd for C11H9ClN2O4S2: C, 39.70; H, 2.73; N, 8.42. Found: C, 39.95; H, 2.69; N, 8.55.

3.4. General Procedure for the Reaction of Compound 1 and Variously Substituted Sulfinate Salts to Synthesize Products 2d to 2l and Using Microwave Irradiation

Sodium sulfite (3.4 equiv.) and sodium bicarbonate (3.4 equiv.) were added to a solution of sulfonyl chloride (600 mg, 1 equiv.) in water (30 mL). The reaction mixture was irradiated in a microwave oven and reaction was carried out under irradiation at 100 °C at 200 W for 0.42 h. Then, compound 1 (300 mg, 1.56 mmol) was added in situ. The reaction mixture was irradiated for 0.5 h under the same conditions. After cooling down, the mixture was then extracted with chloroform (5 × 15 mL). The organic layers were dried over anhydrous sodium sulfate and removed under vacuum. Purification by column chromatography on silica gel, eluting with the appropriate solvent (2d and 2e: CHCl3/EtOAc, 80/20; 2f, 2g, 2h, 2l: CHCl3/Et2O, 80/20; 2j: EtOAc; 2k: CHCl3/petroleum ether/EtOAc, 50/25/25) and recrystallization from i-PrOH gave the corresponding target product.
4-[(4-Bromophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2d): Yellow solid; m.p. 184 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.65 (s, 3H, CH3), 5.23 (s, 2H, CH2), 7.68 (d, J = 8.7 Hz, 2H, 2 × CH), 7.87 (d, J = 8.7 Hz, 2H, 2 × CH); 13C-NMR (DMSO-d6) δ: 20.1 (CH3), 56.2 (CH2), 128.8 (C), 130.3 (2 × CH), 132.6 (2 × CH), 138.0 (C), 143.3 (C), 170.4 (C), C-NO2 not visible under these conditions; Anal. Calcd for C11H9BrN2O4S2: C, 35.02; H, 2.40; N, 7.43. Found: C, 35.05; H, 2.34; N, 7.40.
4-[(4-Fluorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2e): Yellow solid; m.p. 183 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.65 (s, 3H, CH3), 5.22 (s, 2H, CH2), 7.48 (m, 2H, 2 × CH), 7.83 (m, 2H, 2 × CH); 13C-NMR (DMSO-d6) δ: 20.1 (CH3), 56.3 (CH2), 116.8 (d, J = 23.5 Hz, 2 × CH), 131.6 (d, J = 7.0 Hz, 2 × CH), 135.1 (d, J = 4.7 Hz, C), 143.5 (C), 165.5 (d, J = 253.8 Hz, C-F), 170.4 (C), C-NO2 not visible under these conditions; Anal. Calcd for C11H9FN2O4S2: C, 41.77; H, 2.87; N, 8.86. Found: C, 41.75; H, 2.83; N, 8.85.
4-[(3-Fluorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2f): Yellow solid; m.p. 154 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.64 (s, 3H, CH3), 5.27 (s, 2H, CH2), 7.57–7.69 (m, 4H, 4 × CH); 13C-NMR (DMSO-d6) δ: 20.1 (CH3), 56.0 (CH2), 115.3 (d, J = 24.3 Hz, CH), 121.7 (d, J = 20.3 Hz, CH), 124.6 (d, J = 3.4 Hz, CH), 132.0 (d, J = 8.0 Hz, CH), 140.8 (d, J = 7.0 Hz, C), 143.2 (C), 161.8 (d, J = 248.8 Hz, C-F), 170.4 (C), C-NO2 not visible under these conditions; Anal. Calcd for C11H9FN2O4S2: C, 41.77; H, 2.87; N, 8.86. Found: C, 41.36; H, 2.73; N, 8.67.
2-Methyl-5-nitro-4-{[3-(trifluoromethyl)phenylsulfonyl]methyl}-1,3-thiazole (2g): White solid; m.p. 121 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.61 (s, 3H, CH3), 5.33 (s, 2H, CH2), 7.86–8.32 (m, 4H, 4 × CH); 13C-NMR (DMSO-d6) δ: 20.0 (CH3), 56.0 (CH2), 123.4 (q, J = 273.0 Hz, CF3), 125.1 (q, J = 3.9 Hz, CH), 130.0 (q, J = 33.1 Hz, C-CF3), 131.2 (CH), 131.3 (q, J = 3.5 Hz, CH), 132.5 (CH), 139.9 (C), 143.2 (C), 146.6 (C), 170.5 (C); Anal. Calcd for C12H9F3N2O4S2: C, 39.34; H, 2.48; N, 7.65. Found: C, 39.40; H, 2.45; N, 7.54.
4-[(4-Methoxyphenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2h): Brown solid; m.p. 154 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.66 (s, 3H, CH3), 3.85 (s, 3H, CH3), 5.12 (s, 2H, CH2), 7.12 (d, J = 7.2 Hz, 2H, 2 × CH), 7.64 (d, J = 7.2 Hz, 2H, 2 × CH); 13C-NMR (DMSO-d6) δ: 20.1 (CH3), 56.0 (CH3), 56.6 (CH2), 114.7 (2 × CH), 130.2 (C), 130.5 (2 × CH), 143.7 (C), 143.9 (C), 163.8 (C), 170.2 (C); m/z (EI): [M+H]+, found 329.0258. C12H12N2O5S2 requires 329.0260.
4-[(4-Ethylphenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2i): White solid; m.p. 162 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 1.19 (t, J = 7.5 Hz, 3H, CH3), 2.65 (s, 3H, CH3), 2.70 (q, J = 7.5 Hz, 2H, CH2), 5.15 (s, 2H, CH2), 7.46 (d, J = 8.3 Hz, 2H, 2 × CH), 7.64 (d, J = 8.3 Hz, 2H, 2 × CH); 13C-NMR (DMSO-d6) δ: 15.3 (CH3), 20.1 (CH3), 28.3 (CH2), 56.4 (CH2), 128.3 (2 × CH), 128.9 (2 × CH), 136.1 (C), 143.7 (C), 151.2 (C), 170.2 (C), C-NO2 not visible under these conditions; m/z (EI): [M+H]+, found 327.0468. C13H14N2O4S2 requires 327.0468.
2-Methyl-4-(methylsulfonylmethyl)-5-nitro-1,3-thiazole (2j): Brown solid; m.p. 127 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.75 (s, 3H, CH3), 3.13 (s, 3H, CH3), 5.07 (s, 2H, CH2); 13C-NMR (DMSO-d6) δ: 20.2 (CH3), 41.7 (CH3), 54.6 (CH2), 144.4 (C), 170.7 (C), C-NO2 not visible under these conditions; m/z (EI): [M+Na]+, found 258.9815. C6H8N2O4S2 requires 258.9818.
4-[(5-Bromothiophen-2-ylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (2k): Yellow solid; m.p. 167 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.68 (s, 3H, CH3), 5.31 (s, 2H, CH2), 7.45 (d, J = 3.9 Hz, 1H, CH), 7.56 (d, J = 3.9 Hz, 1H, CH); 13C-NMR (DMSO-d6) δ: 20.1 (CH3), 57.3 (CH2), 122.6 (C), 132.4 (CH), 136.5 (CH), 140.0 (C), 143.1 (C), 146.6 (C), 170.5 (C); Anal. Calcd for C9H7BrN2O4S2: C, 28.20; H, 1.84; N, 7.31. Found: C, 27.82; H, 1.76; N, 7.08.
2-Methyl-4-[(naphtalen-2-ylsulfonyl)methyl]-5-nitro-1,3-thiazole (2l): Yellow solid; m.p. 163 °C (i-PrOH); 1H-NMR (DMSO-d6) δ: 2.55 (s, 3H, CH3), 5.28 (s, 2H, CH2), 7.67–7.74 (m, 3H, 3 × CH), 8.09–8.17 (m, 2H, 2 × CH), 8.37 (d, J = 7.7 Hz, 1H, CH), 8.46 (d, J = 7.7 Hz, 1H, CH); 13C-NMR (DMSO-d6) δ: 20.0 (CH3), 56.5 (CH2), 123.4 (CH), 124.9 (CH), 127.2 (CH), 128.6 (CH), 128.8 (CH), 129.4 (CH), 131.1 (CH), 133.8 (CH), 136.1 (C), 143.3 (C), 146.5 (C), 170.2 (C), C-NO2 not visible under these conditions; Anal. Calcd for C15H12N2O4S2: C, 51.71; H, 3.47; N, 8.04. Found: C, 51.64; H, 3.48; N, 7.94.

3.5. General Procedure for the Dichlorination of Compounds 2a to 2e to Synthesize Products 3a to 3e Using Microwave Irradiation

The corresponding sulfone (1 equiv.) was added to a solution of hypochlorite-based bleach (2.6% active chlorine, 10 mL). The reaction mixture was irradiated in a microwave oven and reaction was carried out at 40 °C at 75 W from 1h to 3.75 h. After being cooled down, the mixture was then extracted with chloroform (3 × 20 mL). The organic layers were dried over anhydrous sodium sulfate and removed under vacuum. Purification by column chromatography eluting with CHCl3 and recrystallization from i-PrOH gave the corresponding required product.
4-[Dichloro(phenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (3a): Yellow solid; m.p. 169 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.76 (s, 3H, CH3), 7.57–7.80 (m, 3H, 3 × CH), 8.14–8.18 (m, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.0 (CH3), 29.6 (C), 91.4 (C), 128.6 (2 × CH), 133.0 (2 × CH), 133.1 (C), 135.3 (CH), 143.2 (C), 165.5 (C); Anal. Calcd for C11H8Cl2N2O4S2: C, 35.98; H, 2.20; N, 7.63. Found: C, 36.04; H, 2.11; N, 7.39.
4-[Dichloro(tosyl)methyl]-2-methyl-5-nitro-1,3-thiazole (3b): Yellow solid; m.p. 165 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.49 (s, 3H, CH3), 2.75 (s, 3H, CH3), 7.39 (d, J = 8.2 Hz, 2H, 2 × CH), 8.03 (d, J = 8.2 Hz, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.0 (CH3), 21.8 (CH3), 129.3 (2 × CH), 129.9 (C), 133.1 (2 × CH), 143.4 (C), 146.9 (C), 156.4 (C), 165.3 (C); C-NO2 not visible under these conditions; m/z (EI): [M+H]+, found 380.9532. C12H10Cl2N2O4S2 requires 380.9532.
4-[Dichloro(4-chlorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (3c): Yellow solid; m.p. 165 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.75 (s, 3H, CH3), 7.57 (d, J = 8.7 Hz, 2H, 2 × CH), 8.10 (d, J = 8.7 Hz, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.0 (CH3), 91.4 (C), 129.0 (2 × CH), 131.7 (C), 134.4 (2 × CH), 142.6 (C), 143.3 (C), 165.7 (C); C-NO2 not visible under these conditions; Anal. Calcd for C11H7Cl3N2O4S2: C, 32.89; H, 1.76; N, 6.97. Found: C, 33.12; H, 1.70; N, 7.20.
C11H7N2O4S2, colorless prisms (0.25 × 0.15 × 0.1 mm3), MW = 401.66, orthorhombic, space group P21/c (T = 293 K), a = 15.6219 (1) Å, b = 9.6399 (3) Å, c = 20.5410 (5) Å, α = 90°, β = 90°, γ = 90°; V = 3093.34 (12) Å3, Z = 8, µ = 0.879 mm−1, F(000) = 1616, index ranges 0 ≤ h ≤ 22, 0 ≤ k ≤ 13, −29 ≤ l ≤ 0; θ range = 1.98–31.00°, 199 variables and 0 restraints, were defined for 4807 independent reflections with I ≥ 2σ(I) to R1 = 0.0600, wR2 = 0.1256, GooF = 1.052. CCDC 908240 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge at www.ccdc.cam.ac.uk/data_request/cif of from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; Fax: + 44 (1223) 336033; Email: deposit@ccdc.cam.ac.uk.
4-[(4-Bromophenylsulfonyl)dichloromethyl]-2-methyl-5-nitro-1,3-thiazole (3d): Yellow solid; m.p. 165 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.76 (s, 3H, CH3), 7.75 (d, J = 8.6 Hz, 2H, 2 × CH), 8.03 (d, J = 8.6 Hz, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.1 (CH3), 91.3 (C), 131.3 (C), 132.0 (2 × CH), 132.2 (C), 134.4 (2 × CH), 143.3 (C), 165.7 (C); C-NO2 not visible under these conditions; Anal. Calcd for C11H7BrCl2N2O4S2: C, 29.61; H, 1.58; N, 6.28. Found: C, 29.27; H, 1.51; N, 5.97.
4-[Dichloro(4-fluorophenylsulfonyl)methyl]-2-methyl-5-nitro-1,3-thiazole (3e): Yellow solid; m.p. 145 °C (i-PrOH); 1H-NMR (CDCl3) δ: 2.76 (s, 3H, CH3), 7.26–7.32 (m, 2H, 2 × CH), 8.17–8.23 (m, 2H, 2 × CH); 13C-NMR (CDCl3) δ: 20.1 (CH3), 91.4 (C), 116.1 (d, J = 23.4 Hz, 2 × CH), 129.0 (d, J = 3.2 Hz, C-F), 136.1 (d, J = 10.3 Hz, 2 × CH), 143.3 (C), 164.5 (C), 165.6 (C), 169.6 (C); m/z (EI): [M+H]+, found 384.9280. C11H7FCl2N2O4S2 requires 384.9281.

3.6. In Vitro Biological Evaluation

In Vitro Cytotoxicity Evaluation on CHO and HepG2 Cell Lines
CHO and HepG2 cell lines were maintained at 37 °C, 6% CO2, 14% O2, 80% N2, with 90% humidity in RPMI supplemented with 10% fœtal bovine serum, 1% L-glutamine (200 mM) and penicillin (100 U/mL) / streptomycin (100 µg/mL) (complete RPMI medium).
In vitro cytotoxicity evaluation on CHO and HepG2 cell lines was performed according to the method described by Mosmann [50] with slight modifications. Briefly, 5 × 103 cells in 100 µL of culture medium (RPMI + 10% CO2) were inoculated into each well of 96-well plates and incubated at 37 °C in a humidified 6% CO2, 14% O2, 80% N2 atmosphere. After 24 h incubation, 100 µL of medium with various product concentrations was added and the plates were incubated from 24 h (CHO) to 72 h (HepG2). Duplicate assays were performed for each sample. At the end of the treatment and incubation, the medium was aspirated from the wells and 10 µL yellow MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) solution (5 mg MTT/mL in PBS) was added to each well with 100 µL of medium without fœtal bovine serum. Cells were incubated for 2 h at 37 °C to allow MTT oxidation by mitochondrial dehydrogenase in the viable cells. After 2 h, the MTT solution was aspirated and DMSO (100 µL) was added to each well to dissolve the resulting blue formazan crystals. Plates were then shaken vigorously (300 rpm) for a few minutes. The absorbance was measured at 570 nm with 630 nm as reference wavelength, using a microplate spectrophotometer. DMSO was used as blank and doxorubicin as positive control.
Cell viability was calculated as percentage of control (cells incubated without compound). The 50% cytotoxic concentrations (CHO CC50 and HepG2 CC50) were determined by non-linear regression analysis processed on dose-response curves, using the Table Curve software 2D v.5.0. CC50 values represent the mean value calculated from three independent experiments.

4. Conclusions

We have developed an efficient, rapid and eco-friendly microwave-based method for synthesizing 4-alkyl- and 4-arylsulfonylmethyl-2-methyl-5-nitro-1,3-thiazoles by the reaction of 4-chloromethyl-2-methyl-5-nitro-1,3-thiazole (1) with various substituted sodium sulfinates, either commercially available or obtained from sulfonyl chlorides previously reduced by a sodium-mediated reaction in aqueous medium.
Biological evaluation of these synthesized compounds revealed the promising antiproliferative activity toward HepG2 cell line of most of the dihydrogenated sulfonyl derivatives after metabolic activation. Their dichlorinated analogs were synthesized using hypochlorite-based bleach (2.6% active chlorine) under microwave irradiation. Biological results showed that these compounds were much more cytotoxic toward both cell lines, showing their lack of cellular specificity and confirming that the methyl group next to sulfonyle played a key role in the antiproliferative activity of this series on human liver tumor cells.
These promising results suggest that further research should be done on 4-arylsulfonylmethyl-2-methyl-5-nitro-1,3-thiazoles as potential anticancer agents in the treatment of liver cancer.

Acknowledgments

This work was supported by the CNRS and the University of Aix-Marseille. The authors thank V. Remusat for recording the 1H-NMR and 13C-NMR spectra.

Conflicts of Interest

The authors declare no conflict of interest.
  • Sample Availability: Samples of the compounds 2a to 3e are available from the authors.

References

  1. Krahn, D.; Ottmann, C.; Kaiser, M. Macrocyclic proteasome inhibitors. Curr. Med. Chem. 2011, 18, 5052–5060. [Google Scholar] [CrossRef]
  2. Santarpia, L.; Lippman, S.M.; El-Naggar, A.K. Targeting the MAPK-RAS-RAF signalling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16, 103–119. [Google Scholar] [CrossRef]
  3. Fortin, S.; Wei, L.; Moreau, E.; Lacroix, J.; Côté, M.F.; Petitclerc, E.; Kotra, L.P.; Gaudreault, R.C. Substituted phenyl-4-(2-oxoimidazolin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationships. Eur. J. Med. Chem. 2011, 46, 5327–5342. [Google Scholar] [CrossRef]
  4. Chen, J.; Liu, T.; Wu, R.; Lou, J.; Cao, J.; Dong, X.; Yang, B.; He, Q.; Hu, Y. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents. Bioorg. Med. Chem. 2010, 18, 8478–8484. [Google Scholar]
  5. Bocca, C.; Bozzo, F.; Bassignana, A.; Miglietta, A. Antiproliferative effects of COX-2 inhibitor celecoxib on human breast cancer cell lines. Mol. Cell. Biochem. 2011, 350, 59–70. [Google Scholar] [CrossRef]
  6. Park, J.H.; El-Gamal, M.I.; Lee, Y.S.; Oh, C.H. New imidazo[2,1-b]thiazoles derivatives: Synthesis, in vitro anticancer evaluation, and in silico studies. Eur. J. Med. Chem. 2011, 46, 5769–5777. [Google Scholar] [CrossRef]
  7. Chang, S.; Zhang, Z.; Zhuang, X.; Luo, J.; Cao, X.; Li, H.; Tu, Z.; Lu, X.; Ren, X.; Ding, K. New thiazole carboxamides as potent inhibitors of Akt kinases. Bioorg. Med. Chem. Lett. 2012, 22, 1208–1212. [Google Scholar]
  8. Metzger, J.V. Thiazole and Its Derivatives, 1st ed; John Wiley and Sons: New York, NY, USA, 1979; and references therein. [Google Scholar]
  9. Sykes, R.B.; Cimarusti, C.M.; Bonner, D.P.; Bush, K.; Floyd, D.M.; Georgopapadakou, N.H.; Koster, W.H.; Liu, W.C.; Parker, W.L.; Principe, P.A.; et al. Monocyclic beta-lactam antibiotics produced by bacteria. Nature 1981, 291, 489–491. [Google Scholar]
  10. Angehrn, P.; Reiner, R. Cephalosporin derivatives and their pharmaceutical preparation. Chem. Abstr. 1983, 98, 22269, Eur. Patent 0,058,250, filed 17 February 1981, issued 25 August 1982. [Google Scholar]
  11. Sader, H.S.; Johnson, D.M.; Jones, R.N. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci. Antimicrob. Agents Chemother. 2004, 48, 53–62. [Google Scholar] [CrossRef]
  12. Schumacher, H.R., Jr.; Becker, M.A.; Wortmann, R.L.; MacDonald, P.A.; Hunt, B.; Streit, J.; Lademacher, C.; Joseph-Ridge, N. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Care Res. 2008, 59, 1540–1548. [Google Scholar] [CrossRef]
  13. Barnes, J.; Boutwood, A.; Haines, E.; Lewington, W.; Lister, E.; Haram, B.J. Oral treatment of Trichomonas vaginitis with aminitrozole. Br. Med. J. 1957, 1, 1160–1162. [Google Scholar]
  14. White, A.C. Jr. Nitazoxanide: A new broad spectrum antiparasitic agent. Expert Rev. Anti-Infect. Ther. 2004, 2, 43–50. [Google Scholar] [CrossRef]
  15. Gonzalez Cabrera, D.; Douelle, F.; Feng, T.-S.; Nchinda, A.T.; Younis, Y.; White, K.L.; Wu, Q.; Ryan, E.; Burrows, J.N.; Waterson, D.; et al. Novel orally active antimalarial thiazoles. J. Med. Chem. 2011, 54, 7713–7719. [Google Scholar]
  16. Patai, S.; Rappoport, Z.; Stirling, C. The Chemistry of Sulphones and Sulphoxides, 1st ed; John Wiley and Sons: Chichester, UK, 1988. [Google Scholar]
  17. Simpkins, N.S. Sulphones in Organic Synthesis, 1st ed; Pergamon Press: Oxford, UK, 1993. [Google Scholar]
  18. Crozet, M.D.; Perfetti, P.; Kaafarani, M.; Crozet, M.P.; Vanelle, P. Rapid syntheses of nitroheterocycles that bear a diethyl methylenemalonate group β to a nitro group. Lett. Org. Chem. 2004, 1, 326–330. [Google Scholar] [CrossRef]
  19. Vanelle, P.; De Meo, M.P.; Maldonado, J.; Nouguier, R.; Crozet, M.P.; Laget, M.; Dumenil, G. Genotoxicity in oxazolidine derivatives: Influence of the nitro group. Eur. J. Med. Chem. 1990, 25, 241–250. [Google Scholar] [CrossRef]
  20. Gellis, A.; Kovacic, H.; Boufatah, N.; Vanelle, P. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents. Eur. J. Med. Chem. 2008, 43, 1858–1864. [Google Scholar] [CrossRef]
  21. Crozet, M.D.; Botta, C.; Gasquet, M.; Curti, C.; Remusat, V.; Hutter, S.; Chapelle, O.; Azas, N.; De Meo, M.; Vanelle, P. Lowering of 5-nitroimidazole’s mutagenicity: Towards optimal antiparasitic pharmacophore. Eur. J. Med. Chem. 2009, 44, 653–659. [Google Scholar]
  22. Juspin, T.; Laget, M.; Terme, T.; Azas, N.; Vanelle, P. TDAE-assisted synthesis of new imidazo[2,1-b]thiazole derivatives as anti-infectious agents. Eur. J. Med. Chem. 2010, 45, 840–845. [Google Scholar] [CrossRef]
  23. Bouhlel, A.; Curti, C.; Dumètre, A.; Laget, M.; Crozet, M.D.; Azas, N.; Vanelle, P. Synthesis and evaluation of original amidoximes as antileishmanaial agents. Bioorg. Med. Chem. 2010, 18, 7310–7320. [Google Scholar] [CrossRef]
  24. Verhaeghe, P.; Dumètre, A.; Castera-Ducros, C.; Hutter, S.; Laget, M.; Fersing, C.; Prieri, M.; Yzombard, J.; Sifredi, F.; Rault, S.; et al. 4-Thiophenoxy-2-trichloromethylquinazolines display in vitro selective antiplasmodial activity against the human malaria parasite Plasmodium falciparum. Bioorg. Med. Chem. Lett. 2011, 21, 6003–6006. [Google Scholar]
  25. Crozet, M.P.; Archaimbault, G.; Vanelle, P.; Nouguier, R. Réactions SRN1 en série hétérocycliques: IV: Réactivité des sels du diméthyl-2,2 nitro-5 dioxanne-1,3. Tetrahedron Lett. 1985, 26, 5133–5134. [Google Scholar] [CrossRef]
  26. Zink, L.; Crozet, M.D.; Terme, T.; Vanelle, P. Long distance-SRN1 in nitroimidazole series favored by temperature. Tetrahedron Lett. 2011, 52, 6991–6996. [Google Scholar]
  27. Crozet, M.D.; Zink, L.; Remusat, V.; Curti, C.; Vanelle, P. Efficient microwave-assisted palladium-catalyzed Suzuki-Miyaura cross-coupling reactions in 5-nitroimidazole series. Synthesis 2009, 3150–3156. [Google Scholar]
  28. Kabri, Y.; Verhaeghe, P.; Gellis, A.; Vanelle, P. Regioselective Suzuki-Miyaura reaction: Application to the microwave-promoted synthesis of 4,7-diarylquinazolines. Molecules 2010, 15, 2949–2961. [Google Scholar] [CrossRef]
  29. Crozet, M.D.; Castera-Ducros, C.; Vanelle, P. An efficient microwave-assisted Suzuki cross-coupling reaction of imidazo[1,2-a]pyridines in aqueous medium. Tetrahedron Lett. 2006, 47, 7061–7065. [Google Scholar] [CrossRef]
  30. Cohen, A.; Crozet, M.D.; Rathelot, P.; Vanelle, P. An efficient aqueous microwave-assisted Suzuki-Miyaura cross-coupling reaction in the thiazole series. Green Chem. 2009, 11, 1736–1742. [Google Scholar] [CrossRef]
  31. Hooper, F.E.; Johnson, T.B. The polymerization of 2-methyl-4-chloromethylthiazole. J. Am. Chem. Soc. 1934, 56, 470–471. [Google Scholar] [CrossRef]
  32. Gellis, A.; Vanelle, P.; Kaafarani, M.; Benakli, K.; Crozet, M.P. Synthèse et réactions SRN1 en série 5-nitrothiazole. Tetrahedron 1997, 53, 5471–5484. [Google Scholar] [CrossRef]
  33. Crozet, M.P.; Giraud, L.; Sabuco, J.-F.; Vanelle, P.; Barreau, M. SRN1 reactions of a tetrasubstituted-1,4-benzoquinone. Tetrahedron Lett. 1991, 32, 4125–4128. [Google Scholar] [CrossRef]
  34. Crozet, M.P.; Gellis, A.; Pasquier, C.; Vanelle, P.; Aune, J.-P. Electron transfer reactivity in 5-nitrouracile series. Tetrahedron Lett. 1995, 36, 525–528. [Google Scholar] [CrossRef]
  35. Dallinger, D.; Kappe, C.O. Microwave-assisted synthesis in water as solvent. Chem. Rev. 2007, 107, 2563–2591. [Google Scholar]
  36. Herrero, M.A.; Kremsner, J.M.; Kappe, C.O. Nonthermal microwave effects revisited: On the importance of internal temperature monitoring and agitation in microwave chemistry. J. Org. Chem. 2008, 73, 36–47. [Google Scholar] [CrossRef]
  37. Polshettiwar, V.; Varma, R.S. Aqueous microwave chemistry: A clean and green synthetic tool for rapiddrug discovery. Chem. Soc. Rev. 2008, 37, 1546–1557. [Google Scholar]
  38. Grieco, P.A. Organic Synthesis in Water, 1st ed; Blackie Academic and Professional: London, UK, 1998. [Google Scholar]
  39. Li, C.-J.; Chan, T.H. Comprehensive Organic Reactions in Aqueous Media, 2nd ed; John Wiley and Sons: Hoboken, NJ, USA, 2007. [Google Scholar]
  40. Lindström, U.M. Organic Reactions in Water, 1st ed; Blackwell: Ames, IA, USA, 2007. [Google Scholar]
  41. De Borggraeve, W.M.; Appukkattan, P.; Azzam, R.; Dehaen, W.; Compernolle, F.; Van der Eycken, E.; Hoornaert, G. Synthesis of novel functionalized symmetric bi-2(1H)-pyrazinones. Synlett 2005, 777–780. [Google Scholar]
  42. Gellis, A.; Boufatah, N.; Vanelle, P. Rapid microwave-promoted synthesis of new sulfonylmethylbenzothiazoles in water. Green Chem. 2006, 8, 483–487. [Google Scholar] [CrossRef]
  43. Jia, C.-S.; Dong, Y.-W.; Tu, S.-J.; Wang, G.-W. Microwave-assisted solvent-free synthesis of substituted 2-quinolones. Tetrahedron 2007, 63, 892–897. [Google Scholar] [CrossRef]
  44. Kabri, Y.; Gellis, A.; Vanelle, P. Synthesis of original 2-substituted 4-arylquinazolines (III) by microwave-irradiated Suzuki-Miyaura cross-coupling reactions. Eur. J. Org. Chem. 2009, 24, 4059–4066. [Google Scholar]
  45. Curti, C.; Laget, M.; Ortiz Carle, A.; Gellis, A.; Vanelle, P. Rapid synthesis of sulfone derivatives as potential anti-infectious agents. Eur. J. Med. Chem. 2007, 42, 880–884. [Google Scholar] [CrossRef]
  46. Field, L.; Clark, R.D. Methyl p-tolyl sulfone. Org. Synth. 1958, 38, 62–65. [Google Scholar]
  47. Antane, S.; Bernotas, R.; Li, Y.; McDevitt, R.; Yan, Y. Chloromethyl sulfones from sulfonyl chlorides via a one-pot procedure. Synth. Commun. 2004, 34, 2443–2449. [Google Scholar] [CrossRef]
  48. Liu, L.K.; Chi, Y.; Jen, K. Copper-catalyzed additions of sulfonyl iodides to simple and cyclic alkenes. J. Org. Chem. 1980, 45, 406–410. [Google Scholar] [CrossRef]
  49. Kidwai, M.; Kohli, S.; Kumar, P. Rapid side-chain chlorination of heterocyclic compounds using focused microwave irradiation. J. Chem. Res. 1998, 586–587. [Google Scholar]
  50. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  51. Rodriguez-Antona, C.; Donato, M.T.; Boobis, A.; Edwards, R.J.; Watts, P.S.; Castell, J.V.; Gómez-Lechón, M.J. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: Molecular mechanisms that determine lower expression in cultured cells. Xenobiotica 2002, 32, 505–520. [Google Scholar] [CrossRef]

Share and Cite

MDPI and ACS Style

Cohen, A.; Crozet, M.D.; Rathelot, P.; Azas, N.; Vanelle, P. Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series. Molecules 2013, 18, 97-113. https://doi.org/10.3390/molecules18010097

AMA Style

Cohen A, Crozet MD, Rathelot P, Azas N, Vanelle P. Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series. Molecules. 2013; 18(1):97-113. https://doi.org/10.3390/molecules18010097

Chicago/Turabian Style

Cohen, Anita, Maxime D. Crozet, Pascal Rathelot, Nadine Azas, and Patrice Vanelle. 2013. "Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series" Molecules 18, no. 1: 97-113. https://doi.org/10.3390/molecules18010097

APA Style

Cohen, A., Crozet, M. D., Rathelot, P., Azas, N., & Vanelle, P. (2013). Synthesis and Promising in Vitro Antiproliferative Activity of Sulfones of a 5-Nitrothiazole Series. Molecules, 18(1), 97-113. https://doi.org/10.3390/molecules18010097

Article Metrics

Back to TopTop